Caixin
Apr 08, 2022 04:59 AM
BUSINESS

BeiGene Taps U.S. Auditor in Search for a Way to Dodge Delisting

More than half of BeiGene’s revenue for the first half of 2021 was generated in Switzerland, while 28.9% came from the Chinese mainland.
More than half of BeiGene’s revenue for the first half of 2021 was generated in Switzerland, while 28.9% came from the Chinese mainland.

While regulators in Beijing and Washington debate how to settle a long-running audit standoff, some Chinese companies are blazing their own trails in search of a way to avoid getting kicked off American stock exchanges.

Chinese biotechnology company BeiGene Ltd. hired Boston-based accounting firm Ernst & Young LLP as the principal auditor of its financial statements to be filed with the U.S. Securities and Exchange Commission (SEC), replacing China-based Ernst & Young Hua Ming LLP.

You've accessed an article available only to subscribers
VIEW OPTIONS
Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST